PARIS, Feb 11 (Reuters) - French artificial intelligence startup Mistral AI said on Wednesday it will invest 1.2 billion euros ($1.43 billion) in new data centres in Sweden. "This investment is a ...

French startup Mistral AI is investing €1.2 billion ($1.4 billion) to build AI infrastructure in Sweden, as it pushes to become the go-to artificial intelligence supplier for governments and ...

With tvOS 26.2, Apple is changing the way that profiles work on the Apple TV. It's now possible to create a profile without an Apple Account, which is particularly useful for guest profiles and ...

You can now download iOS 26.2 beta 1 OTA profile and IPSW links for iPhone. Here are the details on the release. As Apple works towards improving iOS 26, the company ...

CHEYENNE, Wyo. — Work has officially begun on Related Digital’s $1.2 billion data center in Cheyenne. Prominent local and state figures joined Related CEO Jeff Blau and other partners at the future ...

XAI Colossus 2’s is targeting ~1 Gigawatt as soon as possible. They have natural gas turbines for primary generation, batteries for stability, and grid for long-term scalability. XAI Colossus 2 has ...

As millions of Americans gather Monday to celebrate Labor Day, federal data shows how President Trump's immigration policies are reshaping the U.S. workforce. The number of immigrant workers in the ...

Getting input from users is one of the first skills every Python programmer learns. Whether you’re building a console app, validating numeric data, or collecting values in a GUI, Python’s input() ...

Jake Fillery is an Evergreen Editor for GameRant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...

Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...

CHICAGO — The investigational non-peptide small-molecule oral GLP-1 agonist orforglipron significantly reduced A1c over 40 weeks in adults with early type 2 diabetes, according to the results of ...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase 1/2 portion of the Phase 1/2/3 ...